Enzymatic Therapies' two new kava products promoted for "normal" mental well-being.
This article was originally published in The Tan Sheet
Executive Summary
ENZYMATIC THERAPIES INTRODUCING KAVA-30 kava capsules, standardized to contain 30% kavalactones, to the trade at Natural Products Expo West in Anaheim, Calif. March 11-15. The new product will be available in a 60-capsule bottle, or a 30-day supply. Kava promotes "normal" mental well-being, the company said, predicting the substance, made from the root of the Piper methysticum plant, could become as popular as St. John's wort for depression. The product will be sold in health food stores alongside other Enzymatic Therapies products, and will retail for about $17.95.